Gene · 1844
Papers2,214
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,214
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrochemical DNA Sensor for Valrubicin Detection Based on Poly(Azure C) Films Deposited from Deep Eutectic Solvent. | Biosensors (Basel) | 2023 | 37887124 | PubTator, text mining | PubMed |
| Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. | Front Immunol | 2023 | 37881427 | PubTator, text mining | PubMed |
| Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer. | J Exp Clin Cancer Res | 2023 | 37880793 | PubTator, text mining | PubMed |
| Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | 37875502 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease. | Commun Biol | 2023 | 37848613 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| The mechanism of oleic acid inhibiting platelet activation stimulated by collagen. | Cell Commun Signal | 2023 | 37817162 | PubTator, text mining | PubMed |
| [Clinical characteristics and efficacy analysis of 11 patients with primary cutaneous diffuse large B-cell lymphoma, leg type]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803847 | PubTator, text mining | PubMed |
| Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. | Nat Commun | 2023 | 37798266 | PubTator, text mining | PubMed |
| First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. | Res Sq | 2023 | 37790486 | PubTator, text mining | PubMed |
| Ayurvedic preparations of Raudra Rasa inhibit agonist-mediated platelet activation and restrict thrombogenicity without affecting cell viability. | FEBS Open Bio | 2023 | 37787005 | PubTator, text mining | PubMed |
| OMIP-097: High-parameter phenotyping of human platelets by spectral flow cytometry. | Cytometry A | 2023 | 37786346 | PubTator, text mining | PubMed |
| Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. | Pharmaceutics | 2023 | 37765202 | PubTator, text mining | PubMed |
| In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments. | Cancers (Basel) | 2023 | 37760412 | PubTator, text mining | PubMed |
| DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7. | Cell Signal | 2023 | 37739277 | PubTator, text mining | PubMed |
| The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. | Melanoma Res | 2023 | 37738028 | PubTator, text mining | PubMed |
| Conserved roles for the dynein intermediate chain and Ndel1 in assembly and activation of dynein. | Nat Commun | 2023 | 37730751 | PubTator, text mining | PubMed |
| Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. | Dis Model Mech | 2023 | 37718909 | PubTator, text mining | PubMed |
| Effect of ticagrelor and clopidogrel dual antiplatelet therapy on MPVLR, MAADP, and AA inhibition rate in acute coronary syndrome patients after percutaneous coronary intervention. | Medicine (Baltimore) | 2023 | 37713840 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1844/papers?page=10